323 related articles for article (PubMed ID: 30630219)
21. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.
Birt L; Wright DJ; Blacklock J; Bond CM; Hughes CM; Alldred DP; Holland R; Scott S
Health Soc Care Community; 2022 Nov; 30(6):e6521-e6531. PubMed ID: 36336895
[TBL] [Abstract][Full Text] [Related]
22. Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2.
Curtin D; Gallagher P; O'Mahony D
Age Ageing; 2021 Feb; 50(2):465-471. PubMed ID: 32997135
[TBL] [Abstract][Full Text] [Related]
23. General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study.
Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
Int J Clin Pract; 2016 Mar; 70(3):261-76. PubMed ID: 26918508
[TBL] [Abstract][Full Text] [Related]
24. Prescribing and deprescribing antihypertensive medication in older people by Dutch general practitioners: a qualitative study.
van Middelaar T; Ivens SD; van Peet PG; Poortvliet RKE; Richard E; Pols AJ; Moll van Charante EP
BMJ Open; 2018 Apr; 8(4):e020871. PubMed ID: 29678989
[TBL] [Abstract][Full Text] [Related]
25. Health professionals' competencies regarding breastfeeding beyond 12 months: a systematic review.
Ojantausta O; Pöyhönen N; Ikonen R; Kaunonen M
Int Breastfeed J; 2023 Oct; 18(1):55. PubMed ID: 37904223
[TBL] [Abstract][Full Text] [Related]
26. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.
Carrier H; Zaytseva A; Bocquier A; Villani P; Verdoux H; Fortin M; Verger P
Br J Gen Pract; 2019 Apr; 69(681):e270-e278. PubMed ID: 30803978
[TBL] [Abstract][Full Text] [Related]
27. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
[TBL] [Abstract][Full Text] [Related]
28. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
[TBL] [Abstract][Full Text] [Related]
29. A systematic review of the evidence for deprescribing interventions among older people living with frailty.
Ibrahim K; Cox NJ; Stevenson JM; Lim S; Fraser SDS; Roberts HC
BMC Geriatr; 2021 Apr; 21(1):258. PubMed ID: 33865310
[TBL] [Abstract][Full Text] [Related]
30. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation.
Lavan AH; Gallagher P; Parsons C; O'Mahony D
Age Ageing; 2017 Jul; 46(4):600-607. PubMed ID: 28119312
[TBL] [Abstract][Full Text] [Related]
31. Challenges and Enablers of Deprescribing: A General Practitioner Perspective.
Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
PLoS One; 2016; 11(4):e0151066. PubMed ID: 27093289
[TBL] [Abstract][Full Text] [Related]
32. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
Anderson K; Freeman C; Foster M; Scott I
J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
[TBL] [Abstract][Full Text] [Related]
33. Determinants of implementing deprescribing for older adults in English care homes: a qualitative interview study.
Warmoth K; Rees J; Day J; Cockcroft E; Aylward A; Pollock L; Coxon G; Craig T; Walton B; Stein K
BMJ Open; 2023 Nov; 13(11):e081305. PubMed ID: 37996237
[TBL] [Abstract][Full Text] [Related]
34. Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study.
Reeve E; Low LF; Hilmer SN
Br J Gen Pract; 2016 Aug; 66(649):e552-60. PubMed ID: 27266865
[TBL] [Abstract][Full Text] [Related]
35. The Views of Indian Practitioners on Deprescribing.
Sweta K; Bhat D; Saraswathy GR; Maheswari E
J Gen Intern Med; 2019 Jun; 34(6):828-830. PubMed ID: 30623381
[No Abstract] [Full Text] [Related]
36. Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: A systematic review.
Shrestha S; Poudel A; Steadman K; Nissen L
Br J Clin Pharmacol; 2020 Oct; 86(10):1931-1945. PubMed ID: 31483057
[TBL] [Abstract][Full Text] [Related]
37. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
[TBL] [Abstract][Full Text] [Related]
38. Deprescribing for older adults in Australia: factors influencing GPs.
Gillespie R; Mullan J; Harrison L
Aust J Prim Health; 2018 Jan; 24(6):463-469. PubMed ID: 30423283
[TBL] [Abstract][Full Text] [Related]
39. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?
Djatche L; Lee S; Singer D; Hegarty SE; Lombardi M; Maio V
J Clin Pharm Ther; 2018 Aug; 43(4):550-555. PubMed ID: 29682764
[TBL] [Abstract][Full Text] [Related]
40. Deprescribing in Older Adults With Cancer and Limited Life Expectancy: An Integrative Review.
Brokaar EJ; van den Bos F; Visser LE; Portielje JEA
Am J Hosp Palliat Care; 2022 Jan; 39(1):86-100. PubMed ID: 33739162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
